Strive (ASST) CEO Matthew Cole reports 185,185 shares and warrants
Matthew Ryan Cole, serving as Chief Executive Officer and a director of Strive, Inc. (ticker: ASST), filed an initial Form 3 reporting his beneficial ownership on the event date 09/12/2025.
Rhea-AI Filing Summary
Matthew Ryan Cole, serving as Chief Executive Officer and a director of Strive, Inc. (ticker: ASST), filed an initial Form 3 reporting his beneficial ownership on the event date 09/12/2025. He directly holds 55,555 shares of Class A common stock and indirectly holds 129,630 shares through LT&C LLC, an entity over which his spouse is the managing member and has sole voting and dispositive power (the reporting person disclaims beneficial ownership except for pecuniary interest). The filing also reports warrants exercisable for the same share amounts (55,555 direct; 129,630 indirect) at an exercise price of $1.35. Each warrant is fully exercisable and will expire on the first anniversary of the effectiveness date of the registration statement covering the resale of the underlying registrable securities. The form is signed by an attorney-in-fact on behalf of Mr. Cole on 09/16/2025.
Positive
- CEO ownership disclosed: Direct holding of 55,555 shares and indirect holding of 129,630 shares demonstrate management equity stake.
- Transparency on warrants: Reporting of fully exercisable warrants and the $1.35 exercise price provides clear terms for potential dilution.
Negative
- None.
Insights
TL;DR: CEO holds both direct and indirect equity and matching warrants, reflecting ownership alignment with shareholders.
The filing is a routine initial Section 16 disclosure showing the CEO's economic exposure to the company through direct shares and additional indirect holdings via LT&C LLC, where the reporting person disclaims voting power because his spouse is the managing member. Reporting of fully exercisable warrants at a stated $1.35 exercise price provides transparency on potential dilution and future share issuance timing tied to the registration statement. This disclosure is standard and important for governance transparency.
TL;DR: The Form 3 documents the CEO's current equity and warrant positions but contains no performance or financing details.
From an investor perspective, the positions reported (55,555 direct; 129,630 indirect) quantify the CEO's stake and potential incremental shares from warrants exercisable at $1.35. The expiration condition tied to a registration statement's effectiveness date limits the public visibility of the warrant maturity until that registration is filed and becomes effective. The filing is informational and does not itself change capital structure beyond disclosure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrant (Right to Buy) | -- | -- | -- |
| holding | Warrant (Right to Buy) | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Represents securities held by LT&C LLC, over which the Reporting Person's spouse, as managing member, has sole voting and dispositive power. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F2. Each warrant is fully exercisable.
- F3. The warrants will expire on the first anniversary of the effectiveness date of the registration statement relating to the resale of the registrable private investment in public equity securities underlying such warrant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Are there any warrants reported by the reporting person on Form 3 for ASST?
What is the nature of the indirect ownership through LT&C LLC?
When was the event date and when was the Form 3 signed?
When do the reported warrants expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.
